{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T02:07:13Z","timestamp":1780538833355,"version":"3.54.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,3]]},"DOI":"10.7759\/cureus.110199","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:41:41Z","timestamp":1780537301000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Fructose and FTO Gene Polymorphism on the Efficacy of GLP-1 and GIP Combination Therapies: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Douglas S","family":"Larner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Obesity and overweight. (2026). Accessed. April 4, 2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/nu13082830","article-title":"Multifactorial basis and therapeutic strategies in metabolism-related diseases","volume":"13","author":"Guerra JV","year":"2021","unstructured":"Guerra JV, Dias MM, Brilhante AJ, Terra MF, Garc\u00eda-Ar\u00e9valo M, Figueira AC. Multifactorial basis and therapeutic strategies in metabolism-related diseases. Nutrients. 2021, 13:2830. 10.3390\/nu13082830","journal-title":"Nutrients"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong HJ","year":"2025","unstructured":"Wong HJ, Sim B, Teo YH, et al.. Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials. Diabetes Care. 2025, 48:292-300. 10.2337\/dc24-1678","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103464","article-title":"Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis","volume":"88","author":"Chu J","year":"2025","unstructured":"Chu J, Zhang H, Wu Y, Huang Y, Zhu T, Zhou Z, Wang H. Efficacy of lifestyle modification combined with GLP-1 receptor agonists on body weight and cardiometabolic biomarkers in individuals with overweight or obesity: a systematic review and meta-analysis. EClinicalMedicine. 2025, 88:103464. 10.1016\/j.eclinm.2025.103464","journal-title":"EClinicalMedicine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/circ.152.suppl_3.4365415","article-title":"Abstract 4365415: Comparative efficacy of glucagon-like peptide-1 receptor agonists and co-agonists for weight loss. among patients without diabetes: a network meta-analysis","volume":"152","author":"Moiz A","year":"2025","unstructured":"Moiz A, Filion K, Reynier P, et al.. Abstract 4365415: Comparative efficacy of glucagon-like peptide-1 receptor agonists and co-agonists for weight loss. among patients without diabetes: a network meta-analysis. Circulation. 2025, 152:4365415. 10.1161\/circ.152.suppl_3.4365415","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S559587","article-title":"Revitalizing GIP: therapeutic potential in metabolic and neurodegenerative disorders","volume":"19","author":"Qiao Y","year":"2026","unstructured":"Qiao Y, Zhou F, Mao T, Gao L. Revitalizing GIP: therapeutic potential in metabolic and neurodegenerative disorders. Diabetes Metab Syndr Obes. 2026, 19:559587. 10.2147\/DMSO.S559587","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1113\/JP289067","article-title":"Intestinal fructose metabolism triggers a glucagon-like peptide-1-\u03b2-cell axis to prevent post-fructose hyperglycaemia","volume":"603","author":"Murao N","year":"2025","unstructured":"Murao N, Seino Y, Morikawa R, et al.. Intestinal fructose metabolism triggers a glucagon-like peptide-1-\u03b2-cell axis to prevent post-fructose hyperglycaemia. J Physiol. 2025, 603:6833-58. 10.1113\/JP289067","journal-title":"J Physiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2337\/db23-292-OR","article-title":"292-OR: High-fat diets containing sucrose and fructose, but not glucose, induce obesity and hepatic insulin resistance via accumulation of diacylglycerols","volume":"72","author":"Park SH","year":"2023","unstructured":"Park SH, Fadhul TI, Ronald Kahn C, Softic S. 292-OR: High-fat diets containing sucrose and fructose, but not glucose, induce obesity and hepatic insulin resistance via accumulation of diacylglycerols. Diabetes. 2023, 72:292-OR. 10.2337\/db23-292-OR","journal-title":"Diabetes"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope KL","year":"2009","unstructured":"Stanhope KL, Schwarz JM, Keim NL, et al.. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans. J Clin Invest. 2009, 119:1322-34. 10.1172\/JCI37385","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031855","article-title":"Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women","volume":"89","author":"Teff KL","year":"2004","unstructured":"Teff KL, Elliott SS, Tsch\u00f6p M, et al.. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab. 2004, 89:2963-72. 10.1210\/jc.2003-031855","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu14061127","article-title":"Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: a narrative review","volume":"14","author":"Coronati M","year":"2022","unstructured":"Coronati M, Baratta F, Pastori D, Ferro D, Angelico F, Del Ben M. Added fructose in non-alcoholic fatty liver disease and in metabolic syndrome: a narrative review. Nutrients. 2022, 14:1127. 10.3390\/nu14061127","journal-title":"Nutrients"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020285","article-title":"Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome","volume":"18","author":"Alwahsh SM","year":"2017","unstructured":"Alwahsh SM, Dwyer BJ, Forbes S, Thiel DH, Lewis PJ, Ramadori G. Insulin production and resistance in different models of diet-induced obesity and metabolic syndrome. Int J Mol Sci. 2017, 18:285. 10.3390\/ijms18020285","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/324093","article-title":"Common variant of FTO gene, rs9939609, and obesity in Pakistani females","volume":"2013","author":"Shahid A","year":"2013","unstructured":"Shahid A, Rana S, Saeed S, Imran M, Afzal N, Mahmood S. Common variant of FTO gene, rs9939609, and obesity in Pakistani females. Biomed Res Int. 2013, 2013:324093. 10.1155\/2013\/324093","journal-title":"Biomed Res Int"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S451401","article-title":"FTO rs17817449 variant increases the risk of severe obesity in a Brazilian cohort: a case-control study","volume":"18","author":"Salum KC","year":"2025","unstructured":"Salum KC, Assis IS, Kopke \u00daA, et al.. FTO rs17817449 variant increases the risk of severe obesity in a Brazilian cohort: a case-control study. Diabetes Metab Syndr Obes. 2025, 18:283-303. 10.2147\/DMSO.S451401","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/en.2007-1457","article-title":"The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain","volume":"149","author":"Fredriksson R","year":"2008","unstructured":"Fredriksson R, H\u00e4gglund M, Olszewski PK, et al.. The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology. 2008, 149:2062-71. 10.1210\/en.2007-1457","journal-title":"Endocrinology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI44403","article-title":"A link between FTO, ghrelin, and impaired brain food-cue responsivity","volume":"123","author":"Karra E","year":"2013","unstructured":"Karra E, O'Daly OG, Choudhury AI, et al.. A link between FTO, ghrelin, and impaired brain food-cue responsivity. J Clin Invest. 2013, 123:3539-51. 10.1172\/JCI44403","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2023.109512","article-title":"Hypothalamic FTO promotes high-fat diet-induced leptin resistance in mice through increasing CX3CL1 expression","volume":"123","author":"Liu S","year":"2024","unstructured":"Liu S, Song S, Wang S, et al.. Hypothalamic FTO promotes high-fat diet-induced leptin resistance in mice through increasing CX3CL1 expression. J Nutr Biochem. 2024, 123:109512. 10.1016\/j.jnutbio.2023.109512","journal-title":"J Nutr Biochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S154978","article-title":"Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNF\u03b1 levels, and food intake of women with morbid obesity","volume":"11","author":"Magno FC","year":"2018","unstructured":"Magno FC, Guaran\u00e1 HC, Fonseca AC, et al.. Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNF\u03b1 levels, and food intake of women with morbid obesity. Diabetes Metab Syndr Obes. 2018, 11:199-207. 10.2147\/DMSO.S154978","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/life15111658","article-title":"Nutrigenomics of obesity: integrating genomics, epigenetics, and diet-microbiome interactions for precision nutrition","volume":"15","author":"Farzand A","year":"2025","unstructured":"Farzand A, Rohin MA, Awan SJ, Ahmad AM, Akram H, Saleem T, Imran MM. Nutrigenomics of obesity: integrating genomics, epigenetics, and diet-microbiome interactions for precision nutrition. Life (Basel). 2025, 15:1658. 10.3390\/life15111658","journal-title":"Life (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.7326\/ANNALS-24-01590","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes : a systematic review of randomized controlled trials","volume":"178","author":"Moiz A","year":"2025","unstructured":"Moiz A, Filion KB, Toutounchi H, Tsoukas MA, Yu OH, Peters TM, Eisenberg MJ. Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes : a systematic review of randomized controlled trials. Ann Intern Med. 2025, 178:199-217. 10.7326\/ANNALS-24-01590","journal-title":"Ann Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2019.170231","article-title":"Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction","volume":"125","author":"Keyhani-Nejad F","year":"2020","unstructured":"Keyhani-Nejad F, Barbosa Yanez RL, Kemper M, Schueler R, Pivovarova-Ramich O, Rudovich N, Pfeiffer AF. Endogenously released GIP reduces and GLP-1 increases hepatic insulin extraction. Peptides. 2020, 125:170231. 10.1016\/j.peptides.2019.170231","journal-title":"Peptides"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i8.1166","article-title":"Fructose as a key player in the development of fatty liver disease","volume":"19","author":"Basaranoglu M","year":"2013","unstructured":"Basaranoglu M, Basaranoglu G, Sabuncu T, Sent\u00fcrk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol. 2013, 19:1166-72. 10.3748\/wjg.v19.i8.1166","journal-title":"World J Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/nu11091987","article-title":"Dietary fructose and the metabolic syndrome","volume":"11","author":"Taskinen MR","year":"2019","unstructured":"Taskinen MR, Packard CJ, Bor\u00e9n J. Dietary fructose and the metabolic syndrome. Nutrients. 2019, 11:1987. 10.3390\/nu11091987","journal-title":"Nutrients"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajcnut.2024.01.007","article-title":"Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review","volume":"119","author":"Huber H","year":"2024","unstructured":"Huber H, Schieren A, Holst JJ, Simon MC. Dietary impact on fasting and stimulated GLP-1 secretion in different metabolic conditions - a narrative review. Am J Clin Nutr. 2024, 119:599-627. 10.1016\/j.ajcnut.2024.01.007","journal-title":"Am J Clin Nutr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2020.0176","article-title":"Serum spexin, adiponectin and leptin levels in polycystic ovarian syndrome in association with FTO gene polymorphism","volume":"92","author":"Beyazit F","year":"2021","unstructured":"Beyazit F, Hiz MM, Turkon H, Unsal MA. Serum spexin, adiponectin and leptin levels in polycystic ovarian syndrome in association with FTO gene polymorphism. Ginekol Pol. 2021, 92:682-8. 10.5603\/GP.a2020.0176","journal-title":"Ginekol Pol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248247","article-title":"The fat mass and obesity-associated (FTO) gene allele rs9939609 and glucose tolerance, hepatic and total insulin sensitivity, in adults with obesity","volume":"16","author":"de Soysa AK","year":"2021","unstructured":"de Soysa AK, Langaas M, Jakic A, Shojaee-Moradie F, Umpleby AM, Grill V, Mostad IL. The fat mass and obesity-associated (FTO) gene allele rs9939609 and glucose tolerance, hepatic and total insulin sensitivity, in adults with obesity. PLoS One. 2021, 16:e0248247. 10.1371\/journal.pone.0248247","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2025.01.021","article-title":"Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation","volume":"138","author":"Moiz A","year":"2025","unstructured":"Moiz A, Filion KB, Tsoukas MA, Yu OH, Peters TM, Eisenberg MJ. Mechanisms of GLP-1 receptor agonist-induced weight loss: a review of central and peripheral pathways in appetite and energy regulation. Am J Med. 2025, 138:934-40. 10.1016\/j.amjmed.2025.01.021","journal-title":"Am J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4174\/astr.2026.110.1.47","article-title":"Combined in-person and home-based circuit exercise improves body composition and hormonal profiles in patients with post-bariatric weight regain: a genotype-stratified single-arm interventional study","volume":"110","author":"Kim TY","year":"2026","unstructured":"Kim TY, Jeon D, Kim JH, Park YS. Combined in-person and home-based circuit exercise improves body composition and hormonal profiles in patients with post-bariatric weight regain: a genotype-stratified single-arm interventional study. Ann Surg Treat Res. 2026, 110:47-55. 10.4174\/astr.2026.110.1.47","journal-title":"Ann Surg Treat Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043596","article-title":"High-fructose diet-induced hyperuricemia accompanying metabolic syndrome-mechanisms and dietary therapy proposals","volume":"20","author":"Lubawy M","year":"2023","unstructured":"Lubawy M, Formanowicz D. High-fructose diet-induced hyperuricemia accompanying metabolic syndrome-mechanisms and dietary therapy proposals. Int J Environ Res Public Health. 2023, 20:3596. 10.3390\/ijerph20043596","journal-title":"Int J Environ Res Public Health"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.5c15101","article-title":"Fermented black soybean and dehulled adlay improve metabolic syndrome via AMPK-SIRT1 activation and gut microbiota modulation","volume":"74","author":"Kuo YR","year":"2026","unstructured":"Kuo YR, Zheng YW, Ho PY, Lo YC, Tsai PJ, Pan MH. Fermented black soybean and dehulled adlay improve metabolic syndrome via AMPK-SIRT1 activation and gut microbiota modulation. J Agric Food Chem. 2026, 74:6864-77. 10.1021\/acs.jafc.5c15101","journal-title":"J Agric Food Chem"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2025.1710267","article-title":"Identification of the role of sugar-sweetened beverages in the progression of a murine metabolic dysfunction-associated steatotic liver disease model","volume":"12","author":"Li YQ","year":"2025","unstructured":"Li YQ, Huang C, Chen J, Yang S, Cheng J, Chen H, Zhou Y. Identification of the role of sugar-sweetened beverages in the progression of a murine metabolic dysfunction-associated steatotic liver disease model. Front Nutr. 2025, 12:1710267. 10.3389\/fnut.2025.1710267","journal-title":"Front Nutr"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26062420","article-title":"A combined GLP-1\/PPARa\/CB1-based therapy to restore the central and peripheral metabolic dysregulation induced by a high-fructose high-fat diet","volume":"26","author":"de Ceglia M","year":"2025","unstructured":"de Ceglia M, Rasheed N, Tovar R, et al.. A combined GLP-1\/PPARa\/CB1-based therapy to restore the central and peripheral metabolic dysregulation induced by a high-fructose high-fat diet. Int J Mol Sci. 2025, 26:2420. 10.3390\/ijms26062420","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1698296","article-title":"\u03b2-cell heterogeneity and molecular plasticity in type 2 diabetes: multi-omics perspectives and the role of gut microbiota","volume":"13","author":"Ruchko E","year":"2025","unstructured":"Ruchko E, Chernysheva M, Sokolov V, Starinnov Z, Sabirov M, Vasiliev A. \u03b2-cell heterogeneity and molecular plasticity in type 2 diabetes: multi-omics perspectives and the role of gut microbiota. Front Cell Dev Biol. 2025, 13:1698296. 10.3389\/fcell.2025.1698296","journal-title":"Front Cell Dev Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1814","article-title":"Sugar, uric acid, and the etiology of diabetes and obesity","volume":"62","author":"Johnson RJ","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Sanchez-Lozada LG, et al.. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes. 2013, 62:3307-15. 10.2337\/db12-1814","journal-title":"Diabetes"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0910","article-title":"Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation","volume":"57","author":"Andreasen CH","year":"2008","unstructured":"Andreasen CH, Stender-Petersen KL, Mogensen MS, et al.. Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes. 2008, 57:95-101. 10.2337\/db07-0910","journal-title":"Diabetes"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006528","article-title":"Genome-wide physical activity interactions in adiposity - a meta-analysis of 200,452 adults","volume":"13","author":"Graff M","year":"2017","unstructured":"Graff M, Scott RA, Justice AE, et al.. Genome-wide physical activity interactions in adiposity - a meta-analysis of 200,452 adults. PLoS Genet. 2017, 13:e1006528. 10.1371\/journal.pgen.1006528","journal-title":"PLoS Genet"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S528669","article-title":"Advances in Mendelian randomization studies of obesity over the past decade: uncovering key genetic mechanisms","volume":"18","author":"Lu X","year":"2025","unstructured":"Lu X, Ji L, Chen D, Lian X, Yuan M. Advances in Mendelian randomization studies of obesity over the past decade: uncovering key genetic mechanisms. Diabetes Metab Syndr Obes. 2025, 18:2399-415. 10.2147\/DMSO.S528669","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-017-0234-0","article-title":"Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus","volume":"9","author":"Saucedo R","year":"2017","unstructured":"Saucedo R, Valencia J, Gutierrez C, et al.. Gene variants in the FTO gene are associated with adiponectin and TNF-alpha levels in gestational diabetes mellitus. Diabetol Metab Syndr. 2017, 9:32. 10.1186\/s13098-017-0234-0","journal-title":"Diabetol Metab Syndr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmab078","article-title":"Protein- and calcium-mediated GLP-1 secretion: a narrative review","volume":"12","author":"Watkins JD","year":"2021","unstructured":"Watkins JD, Koumanov F, Gonzalez JT. Protein- and calcium-mediated GLP-1 secretion: a narrative review. Adv Nutr. 2021, 12:2540-52. 10.1093\/advances\/nmab078","journal-title":"Adv Nutr"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-24733-x","article-title":"Regulation of feeding and metabolism by fat mass and obesity-associated protein in zebrafish","volume":"15","author":"Karimzadeh K","year":"2025","unstructured":"Karimzadeh K, Uju C, Zahmatkesh A, Unniappan S. Regulation of feeding and metabolism by fat mass and obesity-associated protein in zebrafish. Sci Rep. 2025, 15:40979. 10.1038\/s41598-025-24733-x","journal-title":"Sci Rep"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/nu17243945","article-title":"Nutrient-induced remodeling of the adipose-cardiac axis: metabolic flexibility, adipokine signaling, and therapeutic implications for cardiometabolic disease","volume":"17","author":"Pavlovi\u0107 N","year":"2025","unstructured":"Pavlovi\u0107 N, Todorovi\u0107 P, Maglica M, Kumri\u0107 M, Bo\u017ei\u0107 J. Nutrient-induced remodeling of the adipose-cardiac axis: metabolic flexibility, adipokine signaling, and therapeutic implications for cardiometabolic disease. Nutrients. 2025, 17:3945. 10.3390\/nu17243945","journal-title":"Nutrients"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-024-01566-9","article-title":"Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males","volume":"24","author":"Zilstorff DB","year":"2024","unstructured":"Zilstorff DB, Richter MM, Hannibal J, J\u00f8rgensen HL, Sennels HP, Wewer Albrechtsen NJ. Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males. BMC Endocr Disord. 2024, 24:38. 10.1186\/s12902-024-01566-9","journal-title":"BMC Endocr Disord"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper K","year":"2020","unstructured":"Timper K, Del R\u00edo-Mart\u00edn A, Cremer AL, et al.. GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function. Cell Metab. 2020, 31:1189-1205.e13. 10.1016\/j.cmet.2020.05.001","journal-title":"Cell Metab"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00161","article-title":"Fructose consumption contributes to hyperinsulinemia in adolescents with obesity through a GLP-1-mediated mechanism","volume":"104","author":"Galderisi A","year":"2019","unstructured":"Galderisi A, Giannini C, Van Name M, Caprio S. Fructose consumption contributes to hyperinsulinemia in adolescents with obesity through a GLP-1-mediated mechanism. J Clin Endocrinol Metab. 2019, 104:3481-90. 10.1210\/jc.2019-00161","journal-title":"J Clin Endocrinol Metab"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03645-3","article-title":"Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery","volume":"31","author":"German J","year":"2025","unstructured":"German J, Cordioli M, Tozzo V, et al.. Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery. Nat Med. 2025, 31:2269-76. 10.1038\/s41591-025-03645-3","journal-title":"Nat Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfaf110","article-title":"GLP-1-based therapeutics for cardiorenal protection in metabolic diseases","volume":"41","author":"Apperloo EM","year":"2026","unstructured":"Apperloo EM, Heerspink HJ, van Raalte DH, Muskiet MH. GLP-1-based therapeutics for cardiorenal protection in metabolic diseases. Nephrol Dial Transplant. 2026, 41:207-19. 10.1093\/ndt\/gfaf110","journal-title":"Nephrol Dial Transplant"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2025.1729904","article-title":"Research progress on oral glucagon-like peptide-1 receptor agonists in the treatment of diabetes mellitus type 2","volume":"12","author":"Shao Q","year":"2025","unstructured":"Shao Q, Xiong J, Wu J, Mao J, Hu Q. Research progress on oral glucagon-like peptide-1 receptor agonists in the treatment of diabetes mellitus type 2. Front Mol Biosci. 2025, 12:1729904. 10.3389\/fmolb.2025.1729904","journal-title":"Front Mol Biosci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/491329-the-effect-of-fructose-and-fto-gene-polymorphism-on-the-efficacy-of-glp-1-and-gip-combination-therapies-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T01:41:44Z","timestamp":1780537304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/491329-the-effect-of-fructose-and-fto-gene-polymorphism-on-the-efficacy-of-glp-1-and-gip-combination-therapies-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":47,"URL":"https:\/\/doi.org\/10.7759\/cureus.110199","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,3]]}}}